Life Sciences
New research on life sciences from University of Cairo summarized
Published in Biotech Business Week, April 2nd, 2007
Investigators publish new data in the report "Tadalafil as an in vitro sperm motility stimulant." According to a study from Cairo, Egypt, "Tadalafil (Cialis) is a known oral selective phosphodiesterase-5 inhibitor used widely in the management of erectile dysfunction. To assess its ability on human sperm motility in vitro, 70 asthenozoospermic semen specimens delivered by masturbation were investigated."
"Semen samples were divided equally into four tubes, one as a control and to the others tadalafil dissolved solution was added in vitro in three different concentrations (4.0, 1.0, 0.5 mg ml(-1) respectively). The tubes were incubated and were followed up for sperm...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Alzheimer Disease
Scientists discover zinc link to a leading cause of blindness - Blindness
Glaucoma diagnosis may be mistaken in some younger Chinese people - Breast Cancer
UBC discovery may lead to 'smart' therapies for breast, ovarian cancer - Cancer
Morphine kills pain -- not patients - Cancer
Small molecule derived from Rb2/p130 could act as cancer therapeutic - Carcinoma
Sutent achieves first line EAU approval for kidney cancer - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
